CDH15
Basic information
Region (hg38): 16:89171748-89195492
Previous symbols: [ "CDH3", "CDH14" ]
Links
Phenotypes
GenCC
Source:
- intellectual disability, autosomal dominant 3 (Limited), mode of inheritance: AD
- autosomal dominant non-syndromic intellectual disability (Supportive), mode of inheritance: AD
- intellectual disability, autosomal dominant 3 (Limited), mode of inheritance: AD
- intellectual disability, autosomal dominant 3 (Limited), mode of inheritance: AD
- intellectual disability (Disputed Evidence), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Intellectual developmental disorder, autosomal dominant 3 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 19012874 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDH15 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 48 | 56 | ||||
missense | 129 | 27 | 10 | 166 | ||
nonsense | 2 | |||||
start loss | 1 | |||||
frameshift | 6 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 3 | 4 | |||
non coding | 5 | |||||
Total | 0 | 0 | 144 | 80 | 16 |
Variants in CDH15
This is a list of pathogenic ClinVar variants found in the CDH15 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-89171833-T-A | Uncertain significance (Aug 17, 2017) | |||
16-89171853-G-C | not specified | Uncertain significance (May 04, 2022) | ||
16-89179418-C-G | not specified | Uncertain significance (Aug 30, 2022) | ||
16-89179449-A-C | Likely benign (Nov 01, 2023) | |||
16-89179450-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
16-89179472-CT-C | not specified | Uncertain significance (May 04, 2022) | ||
16-89179480-G-A | not specified • CDH15-related disorder | Conflicting classifications of pathogenicity (Mar 27, 2023) | ||
16-89179482-G-T | not specified | Benign (Feb 27, 2019) | ||
16-89179483-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
16-89179484-G-A | CDH15-related disorder | Likely benign (Dec 01, 2023) | ||
16-89179500-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
16-89179500-G-T | not specified | Uncertain significance (Feb 27, 2023) | ||
16-89179503-C-T | not specified | Uncertain significance (Sep 12, 2023) | ||
16-89179504-G-A | Benign (May 01, 2024) | |||
16-89179505-G-T | Likely benign (Apr 01, 2024) | |||
16-89179525-C-T | not specified | Uncertain significance (May 08, 2023) | ||
16-89179526-G-A | not specified | Benign (Jan 23, 2020) | ||
16-89179533-G-A | Likely benign (Jan 01, 2024) | |||
16-89179533-G-T | Intellectual disability, autosomal dominant 1 | Uncertain significance (-) | ||
16-89179538-C-T | not specified | Likely benign (Jan 09, 2020) | ||
16-89179544-C-T | not specified | Likely benign (-) | ||
16-89179547-C-T | not specified | Benign (-) | ||
16-89179551-C-T | Intellectual disability, autosomal dominant 3 | Likely benign (Jan 19, 2022) | ||
16-89179552-G-A | not specified | Uncertain significance (Dec 19, 2022) | ||
16-89179556-C-T | not specified | Likely benign (Sep 06, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDH15 | protein_coding | protein_coding | ENST00000289746 | 14 | 23726 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.77e-14 | 0.188 | 125485 | 0 | 179 | 125664 | 0.000712 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.01 | 591 | 526 | 1.12 | 0.0000342 | 5153 |
Missense in Polyphen | 206 | 203.33 | 1.0131 | 2052 | ||
Synonymous | -2.20 | 294 | 250 | 1.18 | 0.0000179 | 1764 |
Loss of Function | 1.09 | 25 | 31.6 | 0.791 | 0.00000150 | 321 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00344 | 0.00343 |
Ashkenazi Jewish | 0.000101 | 0.0000993 |
East Asian | 0.000785 | 0.000762 |
Finnish | 0.0000472 | 0.0000462 |
European (Non-Finnish) | 0.000316 | 0.000299 |
Middle Eastern | 0.000785 | 0.000762 |
South Asian | 0.000330 | 0.000327 |
Other | 0.000658 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. M-cadherin is part of the myogenic program and may provide a trigger for terminal muscle differentiation.;
- Disease
- DISEASE: Note=A chromosomal aberration involving CDH15 and KIRREL3 is found in a patient with severe mental retardation and dysmorphic facial features. Translocation t(11;16)(q24.2;q24).; DISEASE: Mental retardation, autosomal dominant 3 (MRD3) [MIM:612580]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:19012874}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);Developmental Biology;CDO in myogenesis;Myogenesis;Cell-cell junction organization;Adherens junctions interactions;Cell junction organization;Cell-Cell communication
(Consensus)
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- loftool
- 0.663
- rvis_EVS
- -1.08
- rvis_percentile_EVS
- 7.28
Haploinsufficiency Scores
- pHI
- 0.126
- hipred
- N
- hipred_score
- 0.486
- ghis
- 0.614
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.830
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdh15
- Phenotype
- normal phenotype;
Zebrafish Information Network
- Gene name
- cdh15
- Affected structure
- slow muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- elongated
Gene ontology
- Biological process
- cell morphogenesis;cell-cell junction assembly;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;adherens junction organization;cell-cell adhesion mediated by cadherin;positive regulation of muscle cell differentiation;cell-cell adhesion
- Cellular component
- Golgi apparatus;cytosol;plasma membrane;caveola;cell-cell adherens junction;cell surface;integral component of membrane;catenin complex;neuromuscular junction;extracellular exosome
- Molecular function
- calcium ion binding;protein binding;cytoskeletal protein binding;protein homodimerization activity;cadherin binding